News | Stethoscopes | December 30, 2019

Eko Announces Redesigned CORE Product Line

The redesigned Eko CORE offers active noise cancellation, sleeker design and powerful software to allow medical professionals to more effectively screen for heart disease

eko chest shot

December 30, 2019 — Eko, a digital health company with an AI-powered cardiac screening platform, announced the second generation of its CORE product line. An evolution from Eko's first-generation CORE, the new CORE features powerful amplification and active noise cancellation that enables doctors and nurses to hear heart and lung sounds with greater clarity and screen patients for heart disease, the number one cause of death in the U.S., more effectively.

“When heart and lung sounds are amplified in the screening of heart valve and pulmonary diseases, everything changes,” said Connor Landgraf, co-founder and CEO of Eko. “Our mission at Eko continues to be to enable all healthcare professionals to provide the highest level of cardiac care through non-invasive, reliable products. The redesigned CORE puts the ears of a trained cardiologist in the hands of any doctor or nurse.”

Two hundred years after its invention, the stethoscope is still the most heavily relied upon cardiac and pulmonary screening tool. With a sleeker design, unprecedented active noise cancellation, and forthcoming decision support algorithms, the second-generation CORE will elevate what clinicians already use in every physical exam and close gaps in care created in part by analog stethoscopes.

“The better we can hear and the better we can screen, the better we can care for our patients,” said Dr. Steve Pham, VP of clinical research at Eko and an emergency medicine physician. “The CORE, coupled with Eko’s software, helps convert the device already worn around the neck of 30 million clinicians around the world into a powerful cardiopulmonary screening tool.” 

Since releasing its first-generation CORE in 2015, clinicians at over 4,000 hospitals have used the device to enhance their practice.

The second-generation CORE will be available on Eko’s website to healthcare providers as an attachment to their existing stethoscope (sold as the CORE Digital Attachment) or as a fully assembled digital stethoscope (sold as the CORE Digital Stethoscope) for $199 and $249, respectively.

CORE Digital Attachment and CORE Digital Stethoscope features include: 

  • Active noise-cancellation, perfect for honing in on heart and lung sounds in loud settings 
  • 40x sound amplification with seven volume settings, for enhanced clarity of critical sounds 
  • Easy toggling between acoustic and digital modes 
  • Lithium-ion battery with 10-hour life and micro-USB charging
  • Wireless Bluetooth connection to Eko’s software
  • Save 15, 30, 60 or 120-second recordings with “one click” recording button 

Eko’s software allows users to capture, analyze and share sound data:

  • View sound waveforms and phonocardiograms
  • Eko’s screening algorithms, currently FDA-pending, will assist clinicians in analyzing heart sounds for pathologic murmurs and valvular heart diseases
  • Share recordings with colleagues for a second opinion or live stream cardiology-grade sounds with an Eko Enterprise plan, which powers reliable real-time connections between clinicians and patients, or between clinicians for second opinions 

Eko’s screening algorithms are in development and have not been cleared by the FDA.

For more information: www.ekohealth.com

Related Content

heart disease image
News | Cardiac Diagnostics | December 18, 2019
December 18, 2019 — In their latest report, “...
FDA Warns Troponin Tests Impacted by Biotin Dietary Supplement
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S.
Videos | Cardiac Diagnostics | October 29, 2019
Doctor Clyde Yancy was a keynote speaker and said doctors need to check their assumptions about patients at the door...
79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event

79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event. Image courtesy of University Hospitals.

News | Cardiac Diagnostics | October 16, 2019
Health and wellness screenings are more than just nice events for the community – they can save lives. A Mentor, Ohio,...
Pesticide Exposure May Increase Heart Disease and Stroke Risk

Image courtesy of zefe wu from Pixabay

News | Cardiac Diagnostics | October 15, 2019
On-the-job exposure to high levels of pesticides raised the risk of heart disease and stroke in a generally healthy...
World Heart Federation Launches Global Roadmap on Cardiovascular Disease Prevention Among Diabetics
News | Cardiac Diagnostics | September 04, 2019
At the European Society of Cardiology (ESC) Congress 2019 together with the World Congress of Cardiology, the World...
Insomnia Tied to Higher Risk of Heart Disease and Stroke

Image courtesy of the American Heart Association

News | Cardiac Diagnostics | August 19, 2019
People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke,...
Evolutionary Gene Loss May Help Explain Human Predisposition to Heart Attacks
News | Cardiac Diagnostics | July 29, 2019
The loss of a single gene two to three million years ago in our ancestors may have resulted in a heightened risk of...
U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Overlay Init